Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Bioventus (Nasdaq: BVS) announced that CEO Rob Claypoole will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 9:45 a.m. PT / 12:45 p.m. ET.
The presentation will be available via live webcast on the company's Investors website and will be available for replay through February 14, 2026. The webcast will include a Q&A session.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Key medical device peers like LAB, TMCI, and OFIX show modest gains between 0.26% and 4.76%, but no peers are flagged in momentum scanners, suggesting BVS moves are more stock-specific than broad sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 25 | Conference presentation | Neutral | +5.1% | Piper Sandler healthcare conference presentation and webcast details. |
| Nov 04 | Earnings results | Positive | +15.1% | Q3 2025 results with higher EPS and adjusted EBITDA growth. |
| Oct 28 | Earnings date notice | Neutral | +3.4% | Announcement of Q3 2025 earnings release date and call details. |
| Sep 03 | Conference participation | Neutral | -2.5% | Morgan Stanley global healthcare conference fireside chat announcement. |
| Aug 07 | Conference participation | Neutral | -0.1% | Canaccord Genuity growth conference presentation and webcast information. |
Earnings-related news for BVS has coincided with stronger positive price reactions than routine conference participation updates.
Over the last six months, Bioventus issued several conference and earnings updates. An earnings report on Nov 4, 2025 with revenue of $138.7M and improved EPS saw a strong +15.09% reaction, highlighting sensitivity to financial performance. In contrast, multiple conference presentations on Aug 12, Sep 10, and Dec 3, 2025 produced relatively smaller moves. Today’s J.P. Morgan conference announcement continues this pattern of regular investor-facing events without new financial disclosures.
Market Pulse Summary
This announcement highlights Bioventus’ upcoming presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, with a webcast and replay available through February 14, 2026. Historically, conference notices for Bioventus have had smaller market impact than earnings releases, which previously moved the stock more sharply. Investors may focus on any new details shared at the conference regarding growth, margins, or capital structure beyond this scheduling update.
AI-generated analysis. Not financial advice.
DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:45 a.m. PT (12:45 p.m. ET).
The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available for replay until February 14, 2026.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
When will Bioventus (BVS) present at the J.P. Morgan Healthcare Conference?
How can investors watch the Bioventus (BVS) presentation on January 14, 2026?
Will the Bioventus (BVS) J.P. Morgan presentation be available after the event?
Who is presenting for Bioventus (BVS) at the 44th Annual J.P. Morgan Healthcare Conference?
Will there be a Q&A during the Bioventus (BVS) webcast on January 14, 2026?
